Les Sulewski
Stock Analyst at Truist Securities
(0.26)
# 3,263
Out of 4,496 analysts
3
Total ratings
33.33%
Success rate
-15.36%
Average return
Main Sectors:
Top Industries:
3 Stocks
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
AMRX Amneal Pharmaceuticals | Reiterates: Buy | $7 → $9 | $7.24 | +24.31% | 1 | May 6, 2024 | |
COLL Collegium Pharmaceutical | Maintains: Buy | $37 → $40 | $32.36 | +23.61% | 1 | Feb 26, 2024 | |
PCRX Pacira BioSciences | Maintains: Buy | $60 → $55 | $19.37 | +183.94% | 1 | Aug 3, 2023 |
Amneal Pharmaceuticals
May 6, 2024
Reiterates: Buy
Price Target: $7 → $9
Current: $7.24
Upside: +24.31%
Collegium Pharmaceutical
Feb 26, 2024
Maintains: Buy
Price Target: $37 → $40
Current: $32.36
Upside: +23.61%
Pacira BioSciences
Aug 3, 2023
Maintains: Buy
Price Target: $60 → $55
Current: $19.37
Upside: +183.94%